Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia

Stefan Leucht, John M. Davis

Research output: Contribution to journal › Editorial

9 Scopus citations

Original language	English
Journal	European Archives of Psychiatry and Clinical Neuroscience
Volume	272
Issue number	1
DOIs	https://doi.org/10.1007/s00406-021-01378-1
State	Published - Feb 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{0ab4e26664c14be8a6506dd37cd5fd03,

title = "Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia",

author = "Stefan Leucht and Davis, {John M.}",

year = "2022",

month = feb,

doi = "10.1007/s00406-021-01378-1",

language = "English",

volume = "272",

journal = "European Archives of Psychiatry and Clinical Neuroscience",

issn = "0940-1334",

publisher = "D. Steinkopff-Verlag",

number = "1",

}

TY - JOUR

T1 - Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia

AU - Leucht, Stefan

AU - Davis, John M.

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85123065535&partnerID=8YFLogxK

U2 - 10.1007/s00406-021-01378-1

DO - 10.1007/s00406-021-01378-1

M3 - Editorial

C2 - 35038002

AN - SCOPUS:85123065535

SN - 0940-1334

VL - 272

JO - European Archives of Psychiatry and Clinical Neuroscience

JF - European Archives of Psychiatry and Clinical Neuroscience

IS - 1

ER -